Niki BioSolutions, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Niki BioSolutions, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Of every $100 of net worth, $100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than almost all Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 98% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -10%In 3 years sales changed by -100% while total assets changed by -10%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-0.5×Operating cash was negative last year, while some debt falls due within a year.
Higher than 68% of Healthcare companies in United States.
Cash Cushion Ratio
+0%Cash, after subtracting all debt, equals 0% of its market value (net cash).
Lower than 67% of Healthcare companies in United States.
Tangible Assets Ratio
100%Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 98% of Healthcare companies in United States.
Tangible Net Worth Ratio
100%Of every $100 of net worth, $100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than almost all Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Niki BioSolutions, Inc. made a loss over the last year. Niki BioSolutions, Inc. owes $0.26 for every $1 it owns. Niki BioSolutions, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossNiki BioSolutions, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.25The share price is 0.25 times Niki BioSolutions, Inc.'s book value per share, lower than 97% of Healthcare companies in United States.
Market cap
$6 MThe total market value of all of Niki BioSolutions, Inc.'s shares at today's price (share price × number of shares), smaller than 92% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$23 MWhat Niki BioSolutions, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Dec 2025).
Book value per share
$7.43Net worth divided by the number of shares. The share price of $1.86 is 0.3 times this, which is the P/B above.
Return on equity (ROE)
-17.1%Niki BioSolutions, Inc. lost 17.1% of its shareholders' money over the last year, higher than 67% of Healthcare companies in United States.
Owes vs Owns
0.26×Niki BioSolutions, Inc. owes $0.26 for every $1 it owns (low), lower than 65% of Healthcare companies in United States.
Dividend yield
NoneNiki BioSolutions, Inc. does not currently pay a dividend.
Profit growth
LossNiki BioSolutions, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashNiki BioSolutions, Inc. held $0 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Niki BioSolutions, Inc.: $6 M ÷ $23 M (31 Dec 2025) = 0.3.
What is Niki BioSolutions, Inc.'s return on equity?
Niki BioSolutions, Inc. lost 17.1% of its shareholders' money over the last year, higher than 67% of Healthcare companies in United States.
How much does Niki BioSolutions, Inc. owe compared with what it owns?
Niki BioSolutions, Inc. owes $0.26 for every $1 it owns (low), lower than 65% of Healthcare companies in United States.
Does Niki BioSolutions, Inc. pay a dividend?
No. Niki BioSolutions, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.